Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28323729 | 0.79 | PDXK (0.32) | — | |
| SCHEMBL6449401 | 0.76 | PDE3B (0.35) | ALDH1A1 | |
| SCHEMBL3413310 | 0.74 | JAK3 (0.32) | — | |
| SCHEMBL10836044 | 0.74 | CYP2D6 (0.35) | — | |
| SCHEMBL108460 | 0.72 | — | — | |
| SCHEMBL29512257 | 0.72 | — | — | |
| SCHEMBL26677644 | 0.71 | — | — | |
| SCHEMBL27940650 | 0.71 | KDM4E (0.31) | KDM4EMEN1ALDH1A1LMNAHPGD | |
| SCHEMBL4032938 | 0.71 | NOS3 (0.43) | KDM4EMEN1ALDH1A1KMT2ATRIM24 | |
| SCHEMBL30361412 | 0.71 | NOS3 (0.43) | KDM4EMEN1ALDH1A1KMT2ATRIM24 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | claimed |
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-11-02 | — | — | US | claimed |
| EP-3139902-A2 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2017-03-15 | — | — | EP | claimed |
| WO-2015171738-A2 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-12 | — | — | WO | claimed |
| EP-2931236-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931234-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter and Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| WO-2014093819-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093747-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | disclosed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | disclosed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-2931236-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-2931234-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter and Gamble Company (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-1608377-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS | Affinium Pharmaceuticals, Inc. (CA) | 2005-12-28 | — | — | EP | disclosed |
| EP-1583742-A1 | NOVEL CB 1 RECEPTOUR INVERSE AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-10-12 | — | — | EP | disclosed |
| EP-1539722-A1 | THIAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004082586-A2 | PHAMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS | AFFINIUM PHARMACEUTICALS, INC. (US) | 2004-09-30 | — | — | WO | disclosed |
| WO-2004060870-A1 | NOVEL CB 1 RECEPTOUR INVERSE AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004014884-A1 | THIAZOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170312204-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | LPO, GPX4, DEK | KDM4E 1936/4885MEN1 4370/4885ALDH1A1 876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.